You are here

  • Home
  • Archive
  • Volume 12, Issue 8
  • Use of a penicillin allergy clinical decision rule to enable direct oral penicillin provocation: an international multicentre randomised control trial in an adult population (PALACE): study protocol

Article info

Article menu
Immunology (including allergy)
Protocol
Use of a penicillin allergy clinical decision rule to enable direct oral penicillin provocation: an international multicentre randomised control trial in an adult population (PALACE): study protocol

Authors

  • Ana-Maria Copaescu Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, AustraliaDepartment of Medicine, Division of Allergy and Clinical Immunology, McGill University Health Centre (MUHC), Montreal, Quebec, CanadaThe Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada PubMed articlesGoogle scholar articles
  • Fiona James Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia PubMed articlesGoogle scholar articles
  • Sara Vogrin Department of Medicine, St Vincent's Hospital, University of Melbourne, Fitzroy, Victoria, Australia PubMed articlesGoogle scholar articles
  • Morgan Rose Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, AustraliaDepartment of Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, AustraliaDepartment of Medicine, Austin Health, University of Melbourne, Heidelberg, Victoria, Australia PubMed articlesGoogle scholar articles
  • Kyra Chua Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia PubMed articlesGoogle scholar articles
  • Natasha E Holmes Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, AustraliaDepartment of Critical Care, Melbourne Medical School, The University of Melbourne, Parkville, Victoria, Australia PubMed articlesGoogle scholar articles
  • Nicholas A Turner Department of Infectious Diseases, Duke University Medical Center, Durham, Carolina, USA PubMed articlesGoogle scholar articles
  • Cosby Stone Department of Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA PubMed articlesGoogle scholar articles
  • Elizabeth Phillips Department of Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USAInstitute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Western Australia, Australia PubMed articlesGoogle scholar articles
  • Jason Trubiano Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, AustraliaDepartment of Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, AustraliaDepartment of Medicine, Austin Health, University of Melbourne, Heidelberg, Victoria, AustraliaThe National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia PubMed articlesGoogle scholar articles
  1. Correspondence to Ana-Maria Copaescu; ana.copaescu{at}gmail.com
View Full Text

Citation

Copaescu A, James F, Vogrin S, et al
Use of a penicillin allergy clinical decision rule to enable direct oral penicillin provocation: an international multicentre randomised control trial in an adult population (PALACE): study protocol
BMJ Open 2022;12:e063784. doi: 10.1136/bmjopen-2022-063784

Publication history

  • Received April 17, 2022
  • Accepted June 21, 2022
  • First published August 8, 2022.
Online issue publication 
March 30, 2024
Previous versions
Review history

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.